Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance

Pancreatic cancer is one of the most deadly cancers, ranking amongst the top leading cause of cancer related deaths in developed countries. Features such as dense stroma microenvironment, abnormal signaling pathways, and genetic heterogeneity of the tumors contribute to its chemoresistant characteri...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in oncology 2021-06, Vol.11, p.683788-683788
Main Authors: Xelwa, Ntombikayise, Candy, Geoffrey Patrick, Devar, John, Omoshoro-Jones, Jones, Smith, Martin, Nweke, Ekene Emmanuel
Format: Article
Language:English
Subjects:
chemoresistance
chemotherapy
growth factors
Oncology
pancreatic cancer
signaling pathways
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pancreatic cancer is one of the most deadly cancers, ranking amongst the top leading cause of cancer related deaths in developed countries. Features such as dense stroma microenvironment, abnormal signaling pathways, and genetic heterogeneity of the tumors contribute to its chemoresistant characteristics. Amongst these features, growth factors have been observed to play crucial roles in cancer cell survival, progression, and chemoresistance. Here we review the role of the individual growth factors in pancreatic cancer chemoresistance. Importantly, the interplay between the tumor microenvironment and chemoresistance is explored in the context of pivotal role played by growth factors. We further describe current and future potential therapeutic targeting of these factors.
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2021.683788